⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SBFM News
Sunshine Biopharma Inc.
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
accessnewswire.com
SBFM
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
accessnewswire.com
SBFM
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
accessnewswire.com
SBFM
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
accessnewswire.com
SBFM
Form 8-K
sec.gov
QUCY
SBFM
FIEE
SOWG
INDP
BTTC
VIVK
BGMS
PPBT
YHC
Form 8-K
sec.gov
SBFMW
SBFM